CSI Market
Sign In | Register

Immunovant Inc (IMVT) Annual Balance Sheets

Annual · GAAP · USD millions
Access IMVT quarterly Balance Sheets →
Reviewing balance sheet figures over time helps illustrate how Immunovant Inc manages its resources, obligations, and shareholder equity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Mar 31 2026)
(Mar 31 2025) (Mar 31 2024) (Mar 31 2023) (Mar 31 2022)
Assets
Cash & cash equivalent902.11
Cash & Short-term Investments902.00
Accounts receivable1.13
Income Taxes Receivable, Current NO2.81
Other Current Assets0.00
Prepaid Expense, Current AS42.76
Total Current Assets948.82
Equipment/Property/Plant Net0.44
Other Assets, Noncurrent7.75
Operating Lease Right Of Use Asset0.07
Total Assets957.01
Liabilities
Accounts Payable, Current AC7.54
Accrued Liabilities, Current AC96.63
Other Liabilities, Current0.18
Total Current Liabilities104.42
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
OperatingLeaseLiabilityNoncurrent-
Operating Lease Liability Current0.07
Total Liabilities104.42
Stockholders' Equity
Common Stock Value0.02
Additional Paid In Capital Common Stock2,596.97
Retained Earnings / Accumulated Deficit-1,745.13
Other Equity0.73
Common Stockholder's Equity852.59
Total Stockholder's Equity852.59
Liabilities & Stockholder's Equity957.01
4 historic quarters locked

Sign in to unlock the full Immunovant Inc balance sheet history.

Sign In Create Free Account

About Immunovant Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001764013-26-000064

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.